Article
Nirmatrelvir Resistant SARS-CoV-2 Variants with High Fitness in Vitro
2022-06-07
Abstract excerpt
The oral protease inhibitor nirmatrelvir is expected to play a pivotal role for prevention of severe cases of coronavirus disease 2019 (COVID-19). To facilitate monitoring of potentially emerging resistance, we studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from nirmatrelvir. Resistant variants selected in cell culture harbored different combinations of substitutions in the SARS-CoV-2...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2039cbf-35b6-5fb5-a48c-d39c63681db1
- DOI
- 10.1101/2022.06.06.494921
